Portal de Periódicos da CAPES

Selective Effects of Adriamycin on Murine Host Defense Systems

1982; Wiley; Volume: 65; Issue: 1 Linguagem: Inglês

10.1111/j.1600-065x.1982.tb00427.x

1600-065X

M. Jane Ehrke, Stefan A. Cohen, Enrico Mihich,

PARP inhibition in cancer therapy

Immunological ReviewsVolume 65, Issue 1 p. 55-78 Selective Effects of Adriamycin on Murine Host Defense Systems M. Jane Ehrke, M. Jane Ehrke Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263 (M.J.E. and E.M.).Search for more papers by this authorStefan A. Cohen, Stefan A. Cohen Department of Medicine, State University of New York at Buffalo School of Medicine, The Buffalo General Hospital, Buffalo, NY 14203. U.S.A. (S.A.C.).Search for more papers by this authorEnrico Mihich, Enrico Mihich Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263 (M.J.E. and E.M.).Search for more papers by this author M. Jane Ehrke, M. Jane Ehrke Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263 (M.J.E. and E.M.).Search for more papers by this authorStefan A. Cohen, Stefan A. Cohen Department of Medicine, State University of New York at Buffalo School of Medicine, The Buffalo General Hospital, Buffalo, NY 14203. U.S.A. (S.A.C.).Search for more papers by this authorEnrico Mihich, Enrico Mihich Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263 (M.J.E. and E.M.).Search for more papers by this author First published: August 1982 https://doi.org/10.1111/j.1600-065X.1982.tb00427.xCitations: 41 This work was supported in part by U.S.P.H.S. Grants CA-15142 and Core Grant CA-24538 (EM), and by U.S.P.H.S. Grant CA-28835 and a grant from the Margaret Duffy and Robert Cameron Troup Fund (SAC). AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Allison, A. C., Harington, J. S. & Birbeck, M. (1966) An Examination of the Cytotoxic Effects of Silica on Macropbages. J. exp. Med. 124, 141. Bachur, N. R. (1975) Adriamycin (NSC-i23127) Pharmacology. Cancer Chemother. Rep. 6, 153. Chanmougan, D. & Schwartz, R. S. (1966) Enhancement of Antibody Synthesis by 6-mercaptopurine. J. exp. Med. 124, 363. Cohen, S. A., Ehrke, M. J. & Mihich, E. (1975) Mouse Effector Functions Involved in the Antibody-dependent Cellular Cytotoxicity to Xenogeneic Erythrocytes. J. Immunol. 115, 1007. Cohen, S. A., Ehrke, M. J. & Mihich, E. (1980) Selective Imbalances of Cellular Immune Responses by Adriamycin. In Advances in Enzyme Regulation, ed. G. Weber, p. 335. Pergamon Press. New York . Cudkowicz, G. & Hochman, P. S. (1979) Do Natural Killer Cells Engage in Regulated Reaction Against Self to Ensure Homeostasis Immunol. Rev. 44, 13. Eccles, S. A. (1978) Macrophages and Cancer. In Immunological Aspects of Cancer, ed. J. E. Castro, p. 123. University Park Press, Baltimore . Ehrke, M. J., Cohen, S. A. & Mihich, E. (1978) Selectivity of Inhibition by Anticancer Agents of Mouse Spleen Immune Effector Functions Involved in Responses to Sheep Erythrocytes. Cancer Res. 38, 521. Ehrke, M. J., Ryoyama, K. & Mihich, E. (1981) Generation of Cytotoxic Lymphocytes in Cultures of Spleen Cells from Tumor Bearing Mice: Modification by Adriamycin and Cyclophosphamide Treatment of the Mice. Proc. Amer. Assoc. Cancer Res. 22, 273. Ehrke, M. J., Ryoyama, K., Tomazic, V., Cohen, S. A. & Mihich, E. (1980) Selective Imbalances of Cellular Immune Responses by Adriamycin. Recent Results Cancer Res. 75, 204. Fidler, I. J. (1978) Recognition and Destruction of Target Cells by Tumoricidal Macrophages. Isr. J. Med. Sci. 14, 177. Flohe, L. & Gunzler, W. (1976) Glutathione Dependent Enzymatic Oxidoreduction Reactions. In Glutathione: Metabolism and function, eds. I. M. Arias & W. B. Jakoby, Vol. 6, p. 17. Raven Press, New York . Giuliani, F., Casazza, A. M. & DiMarco, A. (1974) Virologic and Immunologic Properties and Response to Daunomycin and Adriamycin of a Non-regressing Mouse Tumor Derived from MSV-induced Sarcoma. Biomedicine 21, 435. Goodman, J. & Hochstein, P. (1977) Generation of Free Radicals and Lipid Peroxidation by Redox Cycling of Adriamycin and Daunomycin. Biochem. Biophys. Res. Comm. 77, 797. Griswold, D. E., Heppner, G. H. & Calabresi, P. (1972) Selective Suppression of Humoral and Cellular Immunity with Cytosinearabinoside. Cancer Res. 32, 298. Haskill, J. S. (1981) Adriamycin-activated Macrophages as Tumor Growth Inhibitors. Cancer Res. 41, 3852. Hemler, M. E., Cook, H. W. & Lands, W. E. M. (1979) Prostaglandin Biosynthesis can be Triggered by Lip id Peroxides. Arch. Biochem. Biophys. 193, 340. Heppner, G. H. & Calabresi, P. (1972) Suppression by Cytosine Arabinoside of Serum-blocking Factors of Cell-mediated Immunity to Syngeneic Transplants of Mouse Mammary Tumors. J. Nat. Cancer Inst. 48, 1161. Herberman, R. B. & Holden, H. T. (1978) Natural Cell-mediated Immunity. In Advances in Cancer Research, eds. G. Klein & S. Weinhouse, Vol. 27, p. 305. Academic Press, New York . Hersh, E. M. (1973) Modification of Host Defense Mechanism. In Cancer Medicine, eds. J. E. Holland & E. Frei, p. 681. Lea and Febiger. Philadelphia, Pennsylvania . Hersh, E. M. (1974) Immunosuppressive Agents. In Antineoplastic and Immunosuppressive Agents I, eds. A. C. Sartorelli & D. G. Johns, p. 577. Springer-Verlag, New York . Hoffmann, C. C., Ehrke, M. J., Papp, G. & Mihich, E. (1980) Modification of Mouse Immune Responses Against Allogeneic Tumor by Pretreatment of Antigen with Mitomycin C or X-irradiation. J. Immunopharmacol. 2, 213. Leung, K. H. & Mihich, E. (1980) Proslaglandin Modulation of Development of Cell-mediated Immunity in Culture. Nature 288, 597. Leung, K. H. & Mihich, E. (1981) Effects of Prostaglandins on the Development of Cell-mediated Immunity in Culture and on the Cytolytic Activity of In Vivo Generated Effector Cells. Int. J. Immunopharm. 4, (in press). Mantovani, A. (1977) In Vitro and In Vivo Cytotoxicity of Adriamycin and Daunomycin for Murine Macrophages. Cancer Res. 37, 815. Mantovani, A., Candiani, P., Luini, W., Salmona, M., Spreafico, F. & Garattini, S. (1979a) Effects of Chemotherapeutic Agents on Host Defense Mechanisms: Its Possible Relevance for the Antitumoral Activity of These Drugs. In Current Trends in Tumor Immunology, eds. S. Ferrone, S. Gorini, R. B. Herberman & R. A. Reisfeld p. 139. Garland Press, New York . Mantovani, A., Polentarutti, N., Luini, W., Peri, G. & Spreafico, F. (1979c) Role of Host Defense Mechanisms in the Antitumor Activity of Adriamycin and Daunomycin in Mice. J. Nat. Cancer Inst. 63, 61. Mantovani, A., Tagliabue, A., Vecchi, A. & Spreafico, F. (1976a) Effects of Adriamycin and Daunomycin on Spleen Cell Populations in Normal and Tumor Allografted Mice. Eur. J. Cancer 12, 381. Mantovani, A., Vecchi, A., Tagliabue, A. & Spreafico, F. (1976b) The Effects of Adriamycin and Daunomycin on Antitumoral Immune Effector Mechanisms in an Allogeneic System. Eur. J. Cancer 12, 371. Mantovani, A., Vecchi, A., Tagliabue, A. & Spreafico, F. (1979b) The Effect of Chemotherapeutic Agents on Host Defense Mechanisms; Its Relevance for Chemoimmunotherapy Combinations. In Tumor-Associated Antigens and Their Specific Immune Responses, eds. F. Spreafico & R. Arnon, p. 271. Academic Press, New York . Mawas, C., Carey, T. & Mihich, E. (1973) Study of the Immune Responses to Nucleated Cells. I. In Vitro Functional Evaluation of the Immune Effectors Responsible for Complement-dependent Cellular Cytotoxicity. Cell Immunol. 6, 243. Mihich, E. (1971) Preclinical Evaluation of the Interrelationships Between Cancer Chemotherapy and Immunity. In Prediction of Response in Cancer Chemotherapy and Immunity. ed. T. C. Hall, NCI Monograph 34, p. 90. U.S. Government Printing Office. Mihich, E. (1975) Immunosuppression in Cancer Therapeutics. Proceedings of the First International Symposium on Cancer and Transplantation. Transplant. Proc. 7, 275. Mihich, E. (1978) Chemotherapy and Immunotherapy as a Combined Modality of Cancer Treatment- In Advances in Tumor Prevention. Detection and Characterization, Vol. 4, p. 113. Excerpta Media Intl., Amsterdam . Mizel, S. B., Oppenheim, J. J. & Rosenstreich, D. L. (1978) Characterization of Lymphocyte-activating Factor (LAE) Produced by the Macrophage Cell Line, P388D. I. Enhancement of LAF Production by Activated T Lymphocytes J. Immunol. 120, 1497. Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K. & Young, R. C. (1977) Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response. Science 197, 165. Nathan, C. F., Murray, H. W. & Cohn, Z. A. (1980) Current Concepts: The Macrophage as an Effector Cell. New Engl. J. Med. 303, 622. Okada, M., Klimpel, G., Kuppers, R. C. & Henney, C. S. (1979) The Differentiation of Cytotoxic T Cells In Vitro. I. Amplifying Factor(s) in the Primary Response is Lyt l+ Cell Dependent. J. Immunol. 122, 2527. Olson, R. D., MacDonald, J. S., VanBoxtel, C. J., Boerth, R. C., Harbison, R. D., Slonim. A. E., Freeman, R. W. & Oates, J. A. (1980) Regulatory Role of Glutathione and Soluble Sutfhydryl Groups in the Toxicity of Adriamycin. J. Pharmacol. Exp. Therap. 215, 450. Orsini, F. & Mihich, E., (1975) Immunosuppression by Adriamycin (AM) and Daunorubicin (DM). Proc. Amer. Assoc. Cancer Res. 16, 130. Orsini, F., Pavelic, Z. & Mihich, E. (1977) Increased Primary Cell Mediated Immunity in Culture Subsequent to Adriamycin or Daunorubicin Treatment of Spleen Donor Mice. Cancer Res. 37, 1719. Reinherz, E. L. & Schlossman, S. F. (1981) Derivation of Human T-Cell Leukemias. Cancer Res. 41, 4767. Ritz, J., Pesando, J. M., Notis-McConarty, J., Clavell, L. A., Sallan, S. E. & Schlossman, S. F. (1981) Use of Monoclonal Antibodies as Diagnostic and Therapeutic Reagents in Acute Lymphoblastic Leukemia. Cancer Res, 41, 4771. Rustum, Y. M., Grindey, G. B., Hakala, M. T. & Mihich, E. (1976) Multi-factorial Cellular Determinants of the Action of Antimetabolites. In Advances in Enzyme Regulation, ed. G. Weber, 14, p. 281. Pergamon Press, New York and Oxford . Ryoyama, K., Ehrke, M. J. & Mihich, E. (1980) Reduced Sensitivity to “Antigen-specific” Suppression Caused by Adriamycin (AM). Abst. 4th Int. Congr. Immunol. 17, 7.31. Ryoyama, K., Ehrke, M. J. & Mihich, E. (1981) Cell-cell Interactions in The Generation of “Non-specific” Suppressor Cells in Culture and its Modification by Anti-cancer Drugs. In Proceedings of the EORTC Symposium on Immuno-Pharmacologic Effects of Radiotherapy, eds. J. Dubois, B. Serrou & C. Rosenfield, p. 23. Raven Press, New York . Santoni, A., Riccardi, C., Sorci, V. & Herberman, R. (1980) Effects of Adriamycin on the Activity of Mouse Natural Killer Cells. J. Immunol. 124, 2329. Schendel, D. J. & Bach, F. H. (1974) Genetic Control of Cell-Mediated Lympholysis in Mouse. J. exp. Med. 140, 1534. Schwartz, H. S. & Grindey, G. B. (1973) Adriamycin and Daunorubicin: A Comparison of Antitumor Activities and Tissue Uptake in Mice Following Immunosuppression. Cancer Res, 33, 1837. Schwartz, H. & Kanter, P. (1975) Cell Interactions; Determinants of Selective Toxicity of Adriamycin and Daunorubicin. Cancer Chemotherapy Rep. 6, 107. Schwartz, H. S. & Mihich, E. (1973) Species and Tissue Differences in Drug Selectivity. In Drug Resistance and Selectivity: Biochemical and Cellular Basis, ed. E. Mihich, p. 413. Academic Press, New York . Smith, K. A., Gillis, S., Baker, P. E. & McKenzie, D. (1979) T-Cell Growth Factor-mediated T-Cell Proliferation. Ann. N. Y. Acad. Sci. 332, 423. Stoychkov, J. N., Schultz, R. M., Chirigos, M. A., Pavlidis, N. A. & Goldin, A. (1979) Effects of Adriamycin and Cyclophosphamide Treatment on Induction of Macrophage Cytotoxic Function in Mice. Cancer Res. 39, 3014. Tarnowski, G. S., Ralph, P. & Stock, C. C. (1979) Sensitivity to Chemotherapeutic and Immunomodulating Agents of Two Mouse Lymphomas and of a Macrophage Tumor. Cancer Res. 39, 3964. Tomazic, V., Ehrke, M. J. & Mihich, E. (1980) Modulation of the Cytotoxic Response Against Allogeneic Tumor Cells in Culture by Adriamycin. Cancer Res. 40, 2748. Tomazic, V., Ehrke, M. J. & Mihich, E. (1981) Augmentation of the Development of Immune Responses of Mice Against Allogeneic Tumor Cells After Adriamycin Treatment. Cancer Res. 41, 3370. Vecchi, A., Mantovani, A., Tagliabue, A. & Spreafico, F. (1976) A Characterization of Immunosuppressive Activity of Adriamycin and Daunomycin on Humoral Antibody Production and Tumor Allograft Rejection. Cancer Res. 36, 1222. Wells, P. G., Boerth, R. C., Oates, J. A. & Harbison, R. D. (1980) Toxicologic Enhancement by a Combination of Drugs which Deplete Hepatic Glutathione: Acetaminophen and Doxorubicin (Adriamycin). Toxicol. Appl. Pharmacol. 54, 197. Citing Literature Volume65, Issue1August 1982Pages 55-78 ReferencesRelatedInformation